Showing results (1411-1420 of 1,771) with videos related to

Sort By:
Pageof 178
Digestive Diseases (Basel, Switzerland)|September 7, 2022
Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis BDaniel Q Huang, Dong Hyun Lee, Michael H Le, et al.
Egastroenterology|April 8, 2026
Burden of metabolic dysfunction-associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 21, 2022
Non-magnetic ion site disorder effects on the quantum magnetism of a spin-1/2 equilateral triangular lattice antiferromagnetQ Huang, R Rawl, W W Xie, et al.
Alimentary Pharmacology & Therapeutics|March 1, 2022
Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective studyDaniel Q Huang, Kathryn J Fowler, Joy Liau, et al.
Hepatology International|August 21, 2021
A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosisCheng Han Ng, Darren Jun Hao Tan, Kameswara Rishi Yeshayahu Nistala, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activityChen Chen, Yongsheng Chen, Joseph Pontillo, et al.
Digestive Diseases (Basel, Switzerland)|March 13, 2023
Characteristics and Outcomes of Elderly Hepatocellular Carcinoma Patients following Surgical Resection: Systematic Review and Meta-AnalysisElizabeth M Garcia, Sanjna N Nerurkar, Eunice X Tan, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2024
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver diseaseNabil Noureddin, Daniel Q Huang, Ricki Bettencourt, et al.
Pageof 178